Emerging concerns about the effectiveness of beta-blockers in hypertension and the publication of clinical trials such as ASCOT prompted the National Institute for Health and Clinical Excellence to bring forward a partial review of the 2004 hypertension guidelines. This review concluded beta-blockers should not be the preferred agent in routine management, particularly for older people as Dr Mark Davis explains.